sur Moderna, Inc. (NASDAQ:MRNA)
Moderna to Present at December 2024 Investor Conferences
Moderna, Inc. has announced its participation in key investor conferences this December. The company will present at the 7th Annual Evercore ISI HealthCONx Conference on December 4, 2024, at 1:20 pm ET. It will also participate in the Piper Sandler 36th Annual Healthcare Conference on December 5, 2024, at 10:30 am ET.
Interested parties can access live webcasts of these presentations under the "Events and Presentations" section on Moderna's official website. The company assures that replays will be available online for 30 days post-presentation.
Moderna is known for its pioneering work in mRNA technology, particularly its advancements in therapeutic and vaccine development for various diseases. Their efforts have positioned them as a leader in mRNA medicine innovation.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Moderna, Inc.